Regard Newborn Kit (ROi CPS) – Pressure Loss Risk (2024)
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
regard Item Number: 830106006, LD01114F - Newborn Kit containing the component Neo-Tee Resuscitator. Convenience kit to be used in Labor and Delivery.
Brand
ROi CPS LLC
Lot Codes / Batch Numbers
Lot number 104006, Exp. 9/30/2026, UDI (01)10194717119074(17)260930(10)104006, and Lot number 103486, Exp. 8/31/2026, UDI (01)10194717119074(17)260831(10)103486.
Products Sold
Lot number 104006, Exp. 9/30/2026, UDI (01)10194717119074(17)260930(10)104006; and Lot number 103486, Exp. 8/31/2026, UDI (01)10194717119074(17)260831(10)103486.
ROi CPS LLC is recalling regard Item Number: 830106006, LD01114F - Newborn Kit containing the component Neo-Tee Resuscitator. due to There is a potential for the Inline Controller to be using the spring out of specification causing a loss of positive pressure resulting in the Neo-Te. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
There is a potential for the Inline Controller to be using the spring out of specification causing a loss of positive pressure resulting in the Neo-Tee Resuscitator and/or Circuit will not reach the high and low ends of the PIP and PEEP pressure ranges impacting effective ventilation of the patient..
Recommended Action
Per FDA guidance
On 12/26/2024, the recalling firm issued a notice dated 12/26/2024 via email to their sole consignee notifying them of the recall of the convenience kits. The email also contained the notice issued by the manufacturer of the affected device component. The recalling firm's notice explained the reason for recall, the health risk involved, and the actions to be taken by the consignee, which included: (1) CHECK: Please review your inventory to determine if the manufacturer item numbers and lot numbers listed in the above table are in your inventory. (2) QUARANTINE: Please quarantine the kits affected by this notice and do not further distribute to end user facilities. (3) NOTIFY: Immediately notify any customers to whom you have distributed or forwarded product affected by this medical device correction notice. Provide a copy of this notice to all customers who have received impacted product and require a response. Customer responses will be requested to determine effectiveness of this recall. (4) END USERS: End users are instructed to discontinue use of the affected kits and quarantine. Kits are to be returned to the distribution location. (5) REPLY: Reply to this notice by completing the reply form attached and emailing to lacy.stewart@roiscs.com. (6) CORRECTION: ROi CPS, LLC personnel will conduct correction activities at the distribution location to ensure removal of the recalled Mercury Medical item. The enclosed reply form is for the consignee to report they have read and understand the attached notice. The consignee is to indicate whether they have forwarded the notice to all customers who have been shipped the affected product, whether or not they have the consignee has the affected product, and that they have completed the "Quantity on Hand" portion of the reply form.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
MO
Page updated: Jan 10, 2026